Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Elevance Health, Inc. Common Stock (NY:ELV)

349.75 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Oct 21, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Elevance Health, Inc. Common Stock

< Previous 1 2
...
15 16 17 18 19 20 21 22 Next >
Fitch Flags Major Credit Risks Amid Sticky Inflation and High Interest Rates: Bond Market Turmoil Persists
 
Via Benzinga
Topics Economy
4 Million People Lost Medicaid In 3 Months, Will Reach 15 Million Before The Election — How Is This Affecting Biden's Presidential Bid?
 
Via Benzinga
Peering Into Elevance Health's Recent Short Interest
 
Via Benzinga
Elevance Health Announces John Gallina to Retire as CFO
From Elevance Health, Inc.
Via Business Wire
Amerigroup Health Plans to be renamed Wellpoint in January 2024
From Elevance Health, Inc.
Via Business Wire
Morgan Stanley Maintains Overweight Rating for Elevance Health: Here's What You Need To Know
 
Via Benzinga
Expert Ratings for Elevance Health
 
Via Benzinga
6 Amazing Dividend Growth Stocks To Buy Today
A look at six incredibly consistent dividend growth stocks that you can invest in today. 
Via Talk Markets
Looking to Get Richer? These 2 Dividend Stocks Have Doubled in 5 Years
A pharmaceutical company and a health insurance company outperformed the S&P 500 and paid a dividend. 
Via The Motley Fool
Want to Build Wealth? Buy This Proven Healthcare Stock
The health insurer has generated market-beating shareholder returns in the past five years. 
Via The Motley Fool
(ELV) - Analyzing Elevance Health's Short Interest
 
Via Benzinga
Elevance Health's Return On Capital Employed Insights
 
Via Benzinga
Elevance Health Unusual Options Activity For July 19
 
Via Benzinga
Why Amarin Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Biodexa Pharmaceuticals Plc (NASDAQ: BDRX) rose 43% to $6.91. 
Via Benzinga
Elevance Health (ELV) Q2 2023 Earnings Call Transcript
ELV earnings call for the period ending June 30, 2023. 
Via The Motley Fool
These 2 Stocks Are Soaring Wednesday Morning
Favorable earnings results have shareholders excited about these two companies. 
Via The Motley Fool
AT&T, Carvana, Northern Trust, And Other Big Stocks Moving Higher On Wednesday
U.S. stocks traded higher, with the Dow Jones gaining over 250 points on Wednesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Why Elevance Health Stock Is Trading Higher Premarket Today?
Elevance Health Inc (NYSE: ELV) has reported Q2 FY23 adjusted EPS of $9.04, up 13.4% Y/Y, beating the consensus of $8.80. 
Via Benzinga
Elevance Health Reports Second Quarter 2023 Results
From Elevance Health, Inc.
Via Business Wire
Elevance Health's Earnings: A Preview
 
Via Benzinga
Elevance Health Unusual Options Activity
 
Via Benzinga
Peering Into Elevance Health's Recent Short Interest
 
Via Benzinga
Earnings Scheduled For July 19, 2023
Companies Reporting Before The Bell • Ally Financial (NYSE:ALLY) is estimated to report quarterly earnings at $0.92 per share on revenue of $2.09 billion. 
Via Benzinga
United Health Stock Is Flying, It May Only Be The Beginning
UnitedHealth Group is gaining some popularity amongst its peer group, based on analyst price targets and market valuations around future earnings. 
Via MarketBeat
Topics Economy
The Latest Analyst Ratings for Elevance Health
 
Via Benzinga
This Is What Whales Are Betting On Elevance Health
 
Via Benzinga
Where Elevance Health Stands With Analysts
 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 12, 2023
 
Via Benzinga
Elevance Health to Hold Conference Call and Webcast to Discuss Second Quarter Results on July 19, 2023
From Elevance Health, Inc.
Via Business Wire
Surgical Centers, Med-Tech Stocks Up On Pent-Up Surgical Demand
Surgery centers and medtech firms see a surge in demand as joint replacements and other elective surgeries are rescheduled, causing challenges for insurers. 
Via MarketBeat
< Previous 1 2
...
15 16 17 18 19 20 21 22 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.